Interestingly, the difference in anti‐INFα IgG antibodies (2% vs 8.5%, P = 0.12) was not statistically significant between these two hospitalised cohorts, indicating that these antibodies could be responsible for the decreased capacity of these patients to eliminate different infections. The gene discussed is IFNA17; the disease is infection.